Advisors Preferred’s Abiomed Inc ABMD Stock Holding History

Advisors Preferred’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-698	Closed	-$314K	–	235
2018 Q3	$314K	Buy	+698	New	+$275K	0.14%	61
2018 Q2	–	Sell	-77	Closed	-$22K	–	303
2018 Q1	$22K	Buy	+77	New	+$19.5K	0.01%	215
2016 Q4	–	Sell	-1,412	Closed	-$181K	–	275
2016 Q3	$181K	Buy	1,412 +1,300	+1,161%	+$156K	0.08%	84
2016 Q2	$12K	Buy	+112	New	+$11.1K	0.01%	169
2015 Q2	–	Sell	-179	Closed	-$12.8K	–	299
2015 Q1	$12.8K	Buy	+179	New	+$9.72K	0.01%	198

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Advisors Preferred's ABMD Position: Q4 2018 in Review

Advisors Preferred sold out of Abiomed Inc (ABMD) in Q4 2018, closing a stake of 698 shares — an estimated $314K sold.

Advisors Preferred first reported a position in ABMD in Q1 2015 and held it in 5 quarters. The position peaked at $314K in Q3 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

Advisors Preferred reported no remaining Abiomed Inc position as of Q4 2018 after selling out during the quarter.
Advisors Preferred sold 698 Abiomed Inc shares in Q4 2018, an estimated $314K.
Advisors Preferred first reported a position in Abiomed Inc in Q1 2015 and held it in 5 quarters.
Advisors Preferred's Abiomed Inc position peaked at $314K in Q3 2018.
529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Advisors Preferred's 13F filing for Q4 2018, filed 16 Jan 2019.